Arthur Allen, Jean Connors, Stephan Moll and Naomi Yates Explore Key Findings from The RENOVE and APICAT Trials
Anticoagulation Forum shared an inviting post on LinkedIn:
”Just 2 days away! Don’t miss our upcoming webinar: Secondary VTE Prevention: To Reduce or Not to Reduce?
Thursday, August 7 | 12:00 PM ET
We are excited to welcome another expert to our panel: Naomi Yates, PharmD, BCACP, who will join as a moderator to help guide this dynamic conversation on one of the most debated questions in anticoagulation: what’s the right dose, and when should it be reduced?
This live webinar will explore key findings from the RENOVE and API-CAT trials, framed by a historical lens and brought to life by a panel of expert clinicians.
What you’ll learn:
- DOAC dosing strategies for extended secondary VTE prevention
- Evidence-based guidance for individualizing care
- Practical takeaways for real-world treatment
Speakers:
Arthur Allen, PharmD, CACP
Jean Connors, MD
Stephan Moll, MD
Naomi Yates, PharmD, BCACP
There’s still time to register and bring your clinical questions to the panel.”
Register here.
Stay updated on all conferences, webinars and panel discussions on coagulation disorders with Hemostasis Today.
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management
-
Jan 9, 2026, 07:38Bartosz Hudzik on Subacute Coronary Occlusions: Navigating the Gray Zone in CAD Care
-
Jan 9, 2026, 07:27Gregory Piazza on The Role of D-Dimer in VTE Evaluation
-
Jan 9, 2026, 07:19Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
-
Jan 9, 2026, 07:07Taylor Robichaux on Recombinant ADAMTS13 Therapy in cTTP
-
Jan 9, 2026, 06:25Sara Ng: VTE Continues to Plague Modern Oncology